Non‐PCR Ultrasensitive Detection of Viral RNA by a Nanoprobe‐Coupling Strategy: SARS‐CoV‐2 as an Example
Sign Up to like & getrecommendations! Published in 2022 at "Advanced Healthcare Materials"
DOI: 10.1002/adhm.202200031
Abstract: Developing efficient and highly sensitive diagnostic techniques for early detections of pathogenic viruses such as Severe Acute Respiratory Syndrome Coronavirus 2 (SARS‐CoV‐2) is vitally important for preventing its widespread. However, the conventional polymerase chain reaction… read more here.
Keywords: viral rna; detection; strategy; non pcr ... See more keywords
Abstract 3680: Multiomics analysis of triple negative breast cancer identifies potential metabolic vulnerability for overcoming the resistance of neoadjuvant therapy
Sign Up to like & getrecommendations! Published in 2023 at "Cancer Research"
DOI: 10.1158/1538-7445.am2023-3680
Abstract: Triple-negative breast cancer (TNBC) is a heterogeneous disease that remains currently medically incurable. We comprehensively analyzed clinical, proteomic, and metabolomic data of a cohort of 12 highly selected primary TNBCs. Among them, 7 patients after… read more here.
Keywords: triple negative; breast cancer; pcr; non pcr ... See more keywords
Abstract PS18-07: Association between pathological response and tumor genomic profiling in triple negative breast cancer patients treated with neoadjuvant chemotherapy
Sign Up to like & getrecommendations! Published in 2021 at "Cancer Research"
DOI: 10.1158/1538-7445.sabcs20-ps18-07
Abstract: Background: Triple negative breast cancer (TNBC) has a marked molecular diversity that promotes clinical heterogeneity. Less than 40% of TNBC patients will achieve a pathological complete response (pCR) to standard neoadjuvant chemotherapy. Patients who do… read more here.
Keywords: response; cancer; non pcr; pcr ... See more keywords
Post-Neoadjuvant Gemcitabine and Cisplatin with Regional Hyperthermia for Patients with Triple-Negative Breast Cancer and Non-pCR after Neoadjuvant Chemotherapy: A Single-Institute Experience
Sign Up to like & getrecommendations! Published in 2020 at "Breast Care"
DOI: 10.1159/000507473
Abstract: Background: Patients with triple-negative primary breast cancer (TNBC) who have residual invasive carcinoma after neoadjuvant chemotherapy have poor prognosis. Proven adjuvant approaches to reduce the risk of recurrence and improve outcome in patients with non-pathological… read more here.
Keywords: non pcr; breast; neoadjuvant chemotherapy; regional hyperthermia ... See more keywords